Klotho Neurosciences, Inc.
KLTO
$0.7488
$0.068810.12%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 4.23% | -14.29% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.28% | -14.29% | |||
| Operating Income | -19.28% | 14.29% | |||
| Income Before Tax | -83.22% | -8.06% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -83.22% | -8.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -83.22% | -8.06% | |||
| EBIT | -19.28% | 14.29% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -48.52% | -6.98% | |||
| Normalized Basic EPS | -48.52% | -6.74% | |||
| EPS Diluted | -48.52% | -6.98% | |||
| Normalized Diluted EPS | -48.52% | -6.74% | |||
| Average Basic Shares Outstanding | 23.36% | 1.11% | |||
| Average Diluted Shares Outstanding | 23.36% | 1.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||